SEC Form 4 · accession 0001179110-18-001378

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Jan 31, 2018

Accepted (ET)

Feb 1, 2018 · 5:50 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Jan 31, 2018	M	27,733	$22.3919	A	156,587	D
Common shares without par value	Jan 31, 2018	S	890	$62.235	D	155,697	D
Common shares without par value	Jan 31, 2018	S	500	$62.24	D	155,197	D
Common shares without par value	Jan 31, 2018	S	1,798	$62.245	D	153,399	D
Common shares without par value	Jan 31, 2018	S	6,400	$62.25	D	146,999	D
Common shares without par value	Jan 31, 2018	S	2,931	$62.255	D	144,068	D
Common shares without par value	Jan 31, 2018	S	4,613	$62.26	D	139,455	D
Common shares without par value	Jan 31, 2018	S	2,501	$62.265	D	136,954	D
Common shares without par value	Jan 31, 2018	S	5,660	$62.27	D	131,294	D
Common shares without par value	Jan 31, 2018	S	1,340	$62.275	D	129,954	D
Common shares without par value	Jan 31, 2018	S	400	$62.28	D	129,554	D
Common shares without par value	Jan 31, 2018	S	600	$62.285	D	128,954	D
Common shares without par value	Jan 31, 2018	S	100	$62.29	D	128,854	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$22.3919	Jan 31, 2018	M	27,733	D	Feb 18, 2014	Feb 17, 2021	Common shares	27,733	0	D

F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).